Cytek Biosciences COO Paul Christopher Williams resigns effective Sept 27, 2024

Cytek Biosciences, Inc.

COO Paul Christopher Williams resigned on Sept 9, 2024, effective Sept 27, 2024, to pursue another career opportunity.
No replacement has been named; CEO Wenbin Jiang remains in charge.
Resignation is voluntary and not due to any disagreement with the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Paul Christopher Williams

Chief Operating Officer

CTKB · Cytek Biosciences, Inc.

Effective: 2024-09-27
Filed: September 12, 2024, 7:59 PM ET

On September 9, 2024, Paul Christopher Williams submitted his resignation from his position as the Chief Operating Officer of Cytek Biosciences, Inc. (the “Company”), effective as of September 27, 2024, to pursue another career opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Christopher Williams resigned as Chief Operating Officer at Cytek Biosciences, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On September 9, 2024, Paul Christopher Williams submitted his resignation from his position as the Chief Operating Officer of Cytek Biosciences, Inc. (the “Company”), effective as of September 27, 2024, to pursue another career opportunity.

View on SEC.gov

Cytek Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-217558

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.